MIRANDA GRAY: Open Payments
NPI 1982358412 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 71 payments from 21 companies in 2025. Trend: 2023 $780 · 2024 $1,901 · 2025 $1,519
Food & beverage: $1,420Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $272 |
| Incyte Corporation | 8 | $220 |
| ABBVIE INC. | 8 | $162 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| PFIZER INC. | 5 | $99 |
| Myriad Genetic Laboratories, Inc. | 4 | $98 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Tempus AI, Inc | 2 | $50 |
Products named: EPKINLY, IMJUDO, MYRISK, KEYTRUDA, ENHERTU, LIBTAYO, JAKAFI, PLUVICTO.
Industry payments across TX — which companies pay providers there.
